Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: A randomized placebo-controlled trial

Journal of Chinese Integrative Medicine

Volumn 11, Issue 3, 2013, Pages 175-183

  Wang, Tian zhan ^a   Chen, Yu ^b   He, Yan ming ^b   Fu, Xiao dong ^a   Wang, Yi ^b   Xu, Yan qiu ^b   Yang, Hongjie ^b   Xue, Hong li ^b   Liu, Yi ^a   Feng, Xiao tao ^c   Zhang, Teng ^b   Wang, Wen jian ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Chinese herbal; Drugs; Insulin resistance; Metabolic syndrome X; Microalbuminuria; Randomized controlled trials

Indexed keywords

ALBUMIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PLANT MEDICINAL PRODUCT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; YIQI HUAJU QINGLI;

ADULT; AGED; ARTICLE; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 84878657100     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jintegrmed2013032     Document Type: Article

References (28)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15(7): 539-553.
2. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev. 2004; 25(6): 971-1010.
3. Khosla N, Sarafidis PA, Bakris GL. Microalbuminuria. Clin Lab Med. 2006; 26(3): 635-653.
4. He CY, Wang WJ, Li B, Xu DS, Chen WH, Ying J, He YM. Clinical research of Yiqi Sanju Formula in treating central obese men at high risk of metabolic syndrome. J Chin Integr Med. 2007; 5(3): 263-267. Chinese with abstract in English.
5. Lou SY, Liu Y, Ma YY, Chen HY, Chen WH, Ying J, He YM, Wang WJ. Effects of Yiqi Sanju Formula on nonalcoholic fatty liver disease: a randomized controlled trial. J Chin Integr Med. 2008; 6(8): 793-798. Chinese with abstract in English.
6. Wang WJ. Inspection of the relationship between disease and syndrome complex: analogous syndrome complex in the same disease. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011; 31(8): 1023-1024. Chinese with abstract in English.
7. Xue HL, Zhang Z, Wang WJ, Chen WH, Ying J. Effects of "Yiqi Zengmin Recipe" on microalbuminuria and insulin resistance of type 2 diabetic in rats. Zhongguo Lao Nian Xue Za Zhi. 2011; (31): 4213-4215. Chinese.
8. Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2007; 35(5): 390-419. Chinese.
9. Esteghamati A, Rashidi A, Khalilzadeh O, Ashraf H, Abbasi M. Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes. Acta Diabetol. 2010; 47(2): 125-130.
10. Klausen KP, Scharling H, Jensen G, Jensen JS. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension. 2005; 46(1): 33-37.
11. Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome. Isr Med Assoc J. 2006; 8(6): 378-382.
12. Parvanova AI, Trevisan R, Iliev IP, Dimitrov BD, Vedovato M, Tiengo A, Remuzzi G, Ruggenenti P. Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes. 2006; 55(5): 1456-1462.
13. Chan JC, Tomlinson B, Nicholls MG, Swaminathan R, Cheung CK, Woo J, Cockram CS. Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with noninsulin-dependent diabetes (NIDDM). Diabet Med. 1996; 13(2): 150-157.
14. Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes. 1998; 47(5): 793-800.
15. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005; 16(7): 2134-2140.
16. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR; UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003; 63(1): 225-232.
17. Lane JT. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective. Am J Physiol. 2004; 286(3): F442-F450.
18. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002; 106(14): 1777-1782.
19. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007; 2(3): 550-562.
20. Hernandez AV, Usmani A, Rajamanickam A, Moheet A. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials. Am J Cardiovasc Drugs. 2011; 11(2): 115-128.
21. Wang WJ. Foundation and application of aggregation syndrome theory in traditional Chinese medicine. J Chin Integr Med. 2007; 5(2): 111-114. Chinese with abstract in English.
22. Wang WJ. Pay more attention to "analogous syndrome complex in the same disease and treating the same disease with analogous methods". J Chin Integr Med. 2008; 6(5): 441-445. Chinese with abstract in English.
23. Wang SH, Wang WJ, Wang XF, Chen WH. Effect of Astragalus polysaccharides and berberine on carbohydrate metabolism and cell differentiation in 3T3 L1 adipocytes. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004; 24(10): 926-928. Chinese with abstract in English.
24. Liu Y, Lou SY, He YM, Chen WH, Ying J, Wang WJ. Effects of berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3T3-L1 pre-adipocytes. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008; 28(11): 1005-1009. Chinese with abstract in English.
25. He YM, Wang WJ, Chen WH, Ying J. Effects of Pollen Typhae total flavones on mRNA expressions of peroxisome proliferator-activated receptors in 3T3-L1 adipocytes. J Chin Integr Med. 2008; 6(9): 939-941. Chinese with abstract in English.
26. Feng XT, Wang TZ, Leng J, Chen Y, Liu JB, Liu Y, Wang WJ. Palmitate contributes to insulin resistance through downregulation of the Src-mediated phosphorylation of Akt in C2C12 myotubes. Biosci Biotechnol Biochem. 2012; 76(7): 1356-1361.
27. Feng XT, Wang TZ, Chen Y, Liu JB, Liu Y, Wang WJ. Pollen Typhae total flavone improves insulin-induced glucose uptake through the beta-arrestin-2-mediated signaling in C2C12 myotubes. Int J Mol Med, 2012; 30(4): 914-922.
28. Zhang Z, Xue HL, Liu Y, Wang WJ. Yi-Qi-Zeng-Min-Tang, a Chinese medicine, ameliorates insulin resistance in type 2 diabetic rats. World J Gastroenterol. 2011; 17(8): 987-995.